Bayesian Capital Management’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,800
Closed -$490K 268
2025
Q3
$490K Sell
16,800
-800
-5% -$19.6K 0.1% 284
2025
Q2
$405K Buy
+17,600
New +$300K 0.06% 331
2024
Q1
Sell
-9,600
Closed -$201K 877
2023
Q4
$201K Buy
+9,600
New +$170K 0.02% 603
2020
Q3
Sell
-17,402
Closed -$531K 566
2020
Q2
$531K Sell
17,402
-12,700
-42% -$333K 0.12% 231
2020
Q1
$585K Buy
30,102
+22,342
+288% +$696K 0.13% 248
2019
Q4
$252K Sell
7,760
-2,240
-22% -$61.6K 0.04% 476
2019
Q3
$241K Buy
+10,000
New +$291K 0.05% 410
2019
Q1
Sell
-11,400
Closed -$321K 612
2018
Q4
$321K Buy
+11,400
New +$434K 0.07% 392

Other funds holding EYE

Bayesian Capital Management's EYE Position: Q4 2025 in Review

Bayesian Capital Management sold out of National Vision (EYE) in Q4 2025, closing a stake of 16,800 shares — an estimated $490K sold.

Bayesian Capital Management first reported a position in EYE in Q4 2018 and held it in 8 quarters. The position peaked at $585K in Q1 2020. 263 funds tracked by Wall St. Rank hold EYE as of Q4 2025.

  • Bayesian Capital Management reported no remaining National Vision position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 16,800 National Vision shares in Q4 2025, an estimated $490K.
  • Bayesian Capital Management first reported a position in National Vision in Q4 2018 and held it in 8 quarters.
  • Bayesian Capital Management's National Vision position peaked at $585K in Q1 2020.
  • 263 funds tracked by Wall St. Rank held National Vision as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.